Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
EV/Core EBITDA

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 9.987.267.948.955.32

What is the latest EV/Core EBITDA ratio of AUROBINDO PHARMA ?

The latest EV/Core EBITDA ratio of AUROBINDO PHARMA is 9.98 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20249.98
Mar20237.26
Mar20227.94
Mar20218.95
Mar20205.32

How is EV/Core EBITDA of AUROBINDO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 9.98
37.47
Mar2023 7.26
-8.56
Mar2022 7.94
-11.28
Mar2021 8.95
68.23
Mar2020 5.32 -

Other Financial Ratios of AUROBINDO PHARMA


Compare EV/Core EBITDA ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹62,894.8 Cr 4% -6.1% -28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4%

-6.1%

-28.4%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses